Innovations in Insulin Therapy: From Ultra-Rapid to Ultra-Long Acting

Objectives:

• Describe the differences in formulation between ultra-rapid acting insulin analogues and their rapid-acting comparator products.
• Discuss the findings of the ONWARDS trial series evaluating once weekly insulin icodec.
• Reconstruct a patient’s insulin regimen appropriately when insurance coverage necessitates a change in insulin products.

Disclosures: Dr. FitzPatrick does not have any financial disclosures

The Iowa Osteopathic Medical Association is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians and designates this program for a maximum of 1 AOA Category 1-A credits and will report CME and specialty credits commensurate with the extent of the physician's participation in this activity.

Grievance Policy:  IOMA strives to provide continuing medical education programs to fulfill the needs of the attendees and to meet the AOA Uniform Guidelines and AOA Accreditation Requirements. Comments, questions, or complaints should be put in writing and forwarded to IOMA Executive Director at ioma@ioma.org or IOMA, 1415 28th Street, Suite 400, West Des Moines, IA 50266.